Menadione Sodium Bisulfite Injection
Function and Efficacy
This product is a vitamin drug. Vitamin K is a necessary substance for the liver to synthesize factors II, VII, IX, and X. Vitamin K deficiency can cause synthesis disorders or abnormalities of these coagulation factors, and clinically bleeding tendency and prolonged prothrombin time can be seen.
Ingredients
The main ingredient of this product is menadione sodium bisulfite.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Menadione sodium bisulfiteIngredients |
This product is a vitamin drug. Vitamin K is a necessary substance for the liver to synthesize factors II, VII, IX, and X. Vitamin K deficiency can cause synthesis disorders or abnormalities of these coagulation factors, and clinically bleeding tendency and prolonged prothrombin time can be seen. More |
130-37-0 | 4 |
Appearance
This product is a colorless clear liquid, which is easily decomposed by light.
Indication
It is used for hemorrhagic diseases caused by vitamin K deficiency, such as neonatal hemorrhage, vitamin K deficiency caused by intestinal malabsorption and hypoprothrombinemia.
Usage and Dosage
1. Hemostasis: intramuscular injection of 2-4 mg once, 4-8 mg per day; to prevent neonatal hemorrhage, it can be given to pregnant women intramuscularly one week before delivery, 2-4 mg per day. 2. Antispasmodic and analgesic: intramuscular injection, 8-16 mg each time.
Adverse Reactions
1. Redness, swelling and pain may be seen locally. 2. Large doses may cause hemolytic anemia, hyperbilirubinemia and jaundice in newborns and premature infants. It may induce acute hemolytic anemia in patients with erythrocyte 6-phosphate dehydrogenase deficiency. 3. Large doses may cause liver damage. Patients with impaired liver function may use vitamin K1 instead.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Large doses of vitamin K3 can cause hemolytic anemia, hyperbilirubinemia and kernicterus in newborns, especially premature infants, but vitamin K1 is less common. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.
Drug Interactions
1 Oral anticoagulants such as dicoumarol can interfere with the metabolism of vitamin K. If the two drugs are used together, their effects will cancel each other out. 2 Large doses of salicylates, sulfonamides, quinine, quinidine, etc. can also affect the effect of vitamin K.
Storage
Keep away from light and store in a dry and cool place.
Packaging Specification
1ml:4mg
Validity Period
24 months
Manufacturer
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
-
Founded in:
2001-06-22 -
Address:
No. 118, Huagong Road, Dongtou District, Wenzhou -
Tax NO.:
913303007303249630 -
Registered Funds:
327.30432 million yuan -
Website:
-
Email: